Talk to a pharmacist Have questions
Neuroprotection and braingut axis: evaluated in TBI, encephalopathy and serotonergic/dopaminergic dysfunction models, with neurobehavioral and histological protection reported [2]
Immune Cell Gene Signatures for Profiling the Microenvironment of Solid Tumors
()
Under TA875, Wegovy is recommended as an option for weight management in adults when prescribed in specialist weight management services with: At least one weight-related comorbidity Initial BMI of at least 35 kg/m (or lower thresholds of 30 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean family backgrounds) Treatment duration is typically limited to a maximum of 2 years in NHS settings
Severe gastrointestinal conditions Conditions like gastroparesis (delayed stomach emptying) may be worsened by GLP-1 medications, which slow gastric motility further